Related references
Note: Only part of the references are listed.Selective Progesterone Receptor Modulators in Early-Stage Breast Cancer: A Randomized, Placebo-Controlled Phase II Window-of-Opportunity Trial Using Telapristone Acetate
Oukseub Lee et al.
CLINICAL CANCER RESEARCH (2020)
Vilaprisan, a New Selective Progesterone Receptor Modulator in Uterine Fibroid Pharmacotherapy-Will it Really be a Breakthrough?
Michal Ciebiera et al.
CURRENT PHARMACEUTICAL DESIGN (2020)
The Biological Impact of Ulipristal Acetate on Cellular Networks Regulating Uterine Leiomyoma Growth
Andrea Tinelli et al.
CURRENT PHARMACEUTICAL DESIGN (2020)
Epidemiology and management of uterine fibroids
Emma Giuliani et al.
INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS (2020)
Progesterone receptor ligands for the treatment of endometriosis: the mechanisms behind therapeutic success and failure
Fernando M. Reis et al.
HUMAN REPRODUCTION UPDATE (2020)
Expression profiles of E/P receptors and fibrosis in GnRHa-treated and -untreated women with different uterine leiomyomas
Khaleque N. Khan et al.
PLOS ONE (2020)
Ulipristal acetate decreases active TGF-β3 and its canonical signaling in uterine leiomyoma via two novel mechanisms
Terrence D. Lewis et al.
FERTILITY AND STERILITY (2019)
Vilaprisan in women with uterine fibroids: the randomized phase 2b ASTEROID 1 study
Linda D. Bradley et al.
FERTILITY AND STERILITY (2019)
Extracellular matrix in uterine leiomyoma pathogenesis: a potential target for future therapeutics
Md Soriful Islam et al.
HUMAN REPRODUCTION UPDATE (2018)
Ulipristal Acetate and Extracellular Matrix Production in Human Leiomyomas In Vivo: A Laboratory Analysis of a Randomized Placebo Controlled Trial
Jeris Cox et al.
REPRODUCTIVE SCIENCES (2018)
Ulipristal acetate induces cell cycle delay and remodeling of extracellular matrix
So-Jin Shin et al.
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE (2018)
A Comprehensive Review of the Pharmacologic Management of Uterine Leiomyoma
Terrence D. Lewis et al.
BIOMED RESEARCH INTERNATIONAL (2018)
Mechanism of Telapristone Acetate (CDB4124) on Progesterone Receptor Action in Breast Cancer Cells
Batzaya Davaadelger et al.
ENDOCRINOLOGY (2018)
Estrogen Receptors and Signaling in Fibroids: Role in Pathobiology and Therapeutic Implications
Mostafa A. Borahay et al.
REPRODUCTIVE SCIENCES (2017)
Molecular targets of dietary phytochemicals for possible prevention and therapy of uterine fibroids: Focus on fibrosis
Md Soriful Islam et al.
CRITICAL REVIEWS IN FOOD SCIENCE AND NUTRITION (2017)
Immunoexpression of Steroid Hormone Receptors and Proliferation Markers in Uterine Leiomyoma and Normal Myometrial Tissues from the Miniature Pig, Sus scrofa
Kristie Mozzachio et al.
TOXICOLOGIC PATHOLOGY (2016)
Epidemiology of Uterine Fibroids: From Menarche to Menopause
Lauren A. Wise et al.
CLINICAL OBSTETRICS AND GYNECOLOGY (2016)
Esmya®and the PEARL studies: A review
Martin Powell et al.
WOMENS HEALTH (2016)
Changes in proliferating and apoptotic markers of leiomyoma following treatment with a selective progesterone receptor modulator or gonadotropin-releasing hormone agonist
Bo Seong Yun et al.
EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY (2015)
In vivo mechanisms of uterine myoma volume reduction with ulipristal acetate treatment
Guillaume E. Courtoy et al.
FERTILITY AND STERILITY (2015)
Selective progesterone receptor modulators: an update
Giuseppe Benagiano et al.
EXPERT OPINION ON PHARMACOTHERAPY (2014)
Comparison of the Inhibitory Effect of Gonadotropin Releasing Hormone (GnRH) Agonist, Selective Estrogen Receptor Modulator (SERM), Antiprogesterone on Myoma Cell Proliferation In Vitro
Youn-Jee Chung et al.
INTERNATIONAL JOURNAL OF MEDICAL SCIENCES (2014)
Receptors of Hypothalamic-Pituitary-Ovarian-Axis Hormone in Uterine Myomas
Danuta Plewka et al.
BIOMED RESEARCH INTERNATIONAL (2014)
Progesterone Action in Endometrial Cancer, Endometriosis, Uterine Fibroids, and Breast Cancer
J. Julie Kim et al.
ENDOCRINE REVIEWS (2013)
Estrogen receptors and human disease: an update
Katherine A. Burns et al.
ARCHIVES OF TOXICOLOGY (2012)
Protein Expression of Estrogen Receptors α and β and Aromatase in Myometrium and Uterine Leiomyoma
Anelise Olmos Grings et al.
GYNECOLOGIC AND OBSTETRIC INVESTIGATION (2012)
The FIGO classification of causes of abnormal uterine bleeding in the reproductive years
Malcolm G. Munro et al.
FERTILITY AND STERILITY (2011)
Changes in tissue inflammation, angiogenesis and apoptosis in endometriosis, adenomyosis and uterine myoma after GnRH agonist therapy
Khaleque Newaz Khan et al.
HUMAN REPRODUCTION (2010)
Dual actions of progesterone on uterine leiomyoma correlate with the ratio of progesterone receptor A:B
Zhao Ying et al.
GYNECOLOGICAL ENDOCRINOLOGY (2009)
Estrogen receptor α and β expression in uterine leiomyomas from premenopausal women
AJ Jakimiuk et al.
FERTILITY AND STERILITY (2004)
Share Paper
